Turkel Catherine C.

Turkel Catherine C. is listed in filings as Director at Lexaria Bioscience Corp.. This profile follows SEC Form 4 activity through Aug 13, 2024, including purchase activity. Recent filings connect the profile to Lexaria Bioscience Corp. (LEXX). The current snapshot covers public activity from Jul 30, 2024 to Aug 13, 2024. Reported amounts are shown as $5.0K to $40.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.